A study published inClinical Cancer Research found that in patients with unresectable, locally advanced esophageal cancer, ...

In patients with unresectable, locally advanced esophageal cancer, the triple combination of radiation, chemotherapy, and immunotherapy made tumors more amenable to surgery, which was associated with ...

The FDA issued its first stamp of approval for a cell or gene therapy back in 2017 to Novartis' Kymriah. | The gene therapy ...

Scientists at Pennington Biomedical Research Center, along with a colleague from Peking University People's Hospital in China ...

Reported total revenue of $10.3 million and GAAP Net Income of $0.6 million, or $0.02 per diluted shareEntered into an asset purchase agreement ...

The predominant treatment for prostate cancer, a prevalent malignancy in men, is the surgical removal of the prostate (radical prostatectomy) for which biopsy is a prerequisite. However, the high ...

Highlighting studies that underscore how digital technology innovations enable improved self-management, personalized treatments, and seamless communication between patients and healthcare providers, ...

The topline data showed ISM001-055 to have improved the forced vital capacity (FVC) of IPF patients studied 12 weeks after ...

The development of a novel, artificial intelligence (AI)-generated biotechnology has the potential to transform care options ...

Insilico Medicine plans to push its computer-designed drug into pivotal clinical trials after a phase 2a study demonstrated ...